AIRR - ANZCA Institutional Research Repository
Skip navigation
Please use this identifier to cite or link to this item: https://hdl.handle.net/11055/683
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPhillips, S-
dc.contributor.authorStewart, P A-
dc.contributor.authorBilgin, A B-
dc.date.accessioned2018-08-24T01:47:11Z-
dc.date.available2018-08-24T01:47:11Z-
dc.date.issued2013-05-
dc.identifier.citationAnaesthesia and intensive care 2013-05; 41(3): 374-9-
dc.identifier.issn0310-057X-
dc.identifier.urihttp://hdl.handle.net/11055/683-
dc.description.abstractThis survey of anaesthetists in Australia and New Zealand aimed to investigate their attitudes and practice relating to the management of neuromuscular blockade monitoring. All medical practitioner members (3188) of the Australian and New Zealand Societies of Anaesthetists were invited to complete an anonymous survey, which was available online for two months. A total of 678 survey questionnaires were completed (response rate 21%). Most respondents (71.4%) underestimated the incidence of residual neuromuscular blockade and 63.2% believed this to be a significant clinical problem. Objective monitoring of neuromuscular function was used routinely only by 17% of respondents, although 70% believed routine monitoring would reduce the incidence of residual neuromuscular blockade. Only 25% of respondents correctly indicated that quantitative train-of-four counts of greater than 90% were the accepted criteria for safe extubation, with 52% using clinical judgement only. Only 29% of respondents believed neuromuscular function monitors should be part of minimum monitoring standards; quantitative neuromuscular function monitors were not available in 42% of the hospitals in which the respondents practiced. Despite the low response rate, the large sample size and heterogeneity of respondents make the findings of this survey concerning. There is a need for more education, availability of appropriate monitoring equipment and evidence-based guidelines for management of neuromuscular blockade in Australia and New Zealand.-
dc.language.isoeng-
dc.subject.meshAustralia-
dc.subject.meshCross-Sectional Studies-
dc.subject.meshElectronic Mail-
dc.subject.meshHealth Care Surveys-
dc.subject.meshHealth Facility Size-
dc.subject.meshHealth Knowledge, Attitudes, Practice-
dc.subject.meshHumans-
dc.subject.meshMonitoring, Physiologic-
dc.subject.meshNeuromuscular Blockade-
dc.subject.meshNeuromuscular Blocking Agents-
dc.subject.meshNew Zealand-
dc.subject.meshPersonnel, Hospital-
dc.subject.meshPhysicians-
dc.subject.meshPostoperative Complications-
dc.subject.meshSynaptic Transmission-
dc.titleA survey of the management of neuromuscular blockade monitoring in Australia and New Zealand.-
dc.typeJournal Article-
dc.typeResearch Support, Non-U.S. Gov't-
dc.identifier.journaltitleAnaesthesia and intensive care-
dc.description.pubmedurihttps://www.ncbi.nlm.nih.gov/pubmed/23659401-
dc.identifier.pubmedid23659401-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.languageiso639-1en-
item.cerifentitytypePublications-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
item.openairetypeResearch Support, Non-U.S. Gov't-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
Appears in Collections:Scholarly and Clinical
Show simple item record

Page view(s)

48
checked on Mar 28, 2024

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.